132 related articles for article (PubMed ID: 7251374)
21. Nasopharyngeal carcinoma. A "different" head and neck tumour. Part A: from histology to staging.
Cantù G
Acta Otorhinolaryngol Ital; 2023 Apr; 43(2):85-98. PubMed ID: 37099432
[TBL] [Abstract][Full Text] [Related]
22. Detection of Epstein-Barr virus-derived latent membrane protein-1 gene in various head and neck cancers: is it specific for nasopharyngeal carcinoma?
Tsang NM; Chang KP; Lin SY; Hao SP; Tseng CK; Kuo TT; Tsai MH; Chung TC
Laryngoscope; 2003 Jun; 113(6):1050-4. PubMed ID: 12782821
[TBL] [Abstract][Full Text] [Related]
23. Validity of clinic biopsy specimens in classifying histopathologic characteristics of recurrent nasopharyngeal carcinoma.
Brown JJ; Berry GJ; Moretto J; Keating WF; Fee WE
Arch Otolaryngol Head Neck Surg; 1997 Sep; 123(9):950-5. PubMed ID: 9305245
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of keratinization in nasopharyngeal carcinoma.
Reddy SP; Raslan WF; Gooneratne S; Kathuria S; Marks JE
Am J Otolaryngol; 1995; 16(2):103-8. PubMed ID: 7540805
[TBL] [Abstract][Full Text] [Related]
25. Histological types of nasopharyngeal carcinoma in an intermediate risk area.
Cammoun M; Ellouz R; Behi J; Attia RB
IARC Sci Publ (1971); 1978; (20):13-26. PubMed ID: 215511
[TBL] [Abstract][Full Text] [Related]
26. [Histologic classification of nasopharyngeal carcinoma].
Wei KR; Xu Y; Zhang WJ; Liang ZH; Liu J
Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):355-7. PubMed ID: 21756838
[No Abstract] [Full Text] [Related]
27. Immunohistochemical study of nasopharyngeal carcinoma using monoclonal keratin antibodies.
Shi SR; Goodman ML; Bhan AK; Pilch BZ; Chen LB; Sun TT
Am J Pathol; 1984 Oct; 117(1):53-63. PubMed ID: 6207735
[TBL] [Abstract][Full Text] [Related]
28. A prospective evaluation of patients with nasopharyngeal carcinoma: an overview.
Neel HB
J Otolaryngol; 1986 Jun; 15(3):137-44. PubMed ID: 3014165
[TBL] [Abstract][Full Text] [Related]
29. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
[TBL] [Abstract][Full Text] [Related]
30. Histopathological types of nasopharyngeal carcinoma in a low-risk area: Japan.
Sugano H; Sakamoto G; Sawaki S; Hirayama T
IARC Sci Publ (1971); 1978; (20):27-39. PubMed ID: 215515
[TBL] [Abstract][Full Text] [Related]
31. Carcinoma of the nasopharynx. The significance of lymphocytic infiltration.
Roth SL; Krueger GF; Bertram G; Sack H
Acta Oncol; 1990; 29(7):897-901. PubMed ID: 2261205
[TBL] [Abstract][Full Text] [Related]
32. [Histo-prognostic classification of undifferentiated carcinoma of nasopharyngeal type. Importance of the study of the stroma].
Elouaret Y; Micheau C; Bosq J; Caillaud JM; Schwaab G; Tursz T; Sancho-Garnier H; De Thé G
Ann Otolaryngol Chir Cervicofac; 1986; 103(3):145-58. PubMed ID: 3752853
[TBL] [Abstract][Full Text] [Related]
33. Histological types of nasopharyngeal carcinoma as compared to EBV serology.
Krueger GR; Kottaridis SD; Wolf H; Ablashi DV; Sesterhenn K; Bertram G
Anticancer Res; 1981; 1(4):187-94. PubMed ID: 6285799
[TBL] [Abstract][Full Text] [Related]
34. Adenoid squamous cell carcinoma of the nasopharynx and neck region.
Zaatari GS; Santoianni RA
Arch Pathol Lab Med; 1986 Jun; 110(6):542-6. PubMed ID: 3518653
[TBL] [Abstract][Full Text] [Related]
35. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space.
Gale N; Poljak M; Zidar N
Head Neck Pathol; 2017 Mar; 11(1):23-32. PubMed ID: 28247231
[TBL] [Abstract][Full Text] [Related]
36. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
[TBL] [Abstract][Full Text] [Related]
37. [2005 WHO histological classification of tumours of the nasopharynx and TNM classification of carcinoma].
Wang SY; Zhu L; Li SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Aug; 42(8):638-40. PubMed ID: 17944224
[No Abstract] [Full Text] [Related]
38. Second primary epithelial malignancy of nasopharynx and nasal cavity after successful curative radiation therapy of nasopharyngeal carcinoma.
Chen CL; Hsu MM
Hum Pathol; 2000 Feb; 31(2):227-32. PubMed ID: 10685638
[TBL] [Abstract][Full Text] [Related]
39. A comparison of Ho's, International Union Against Cancer, and American Joint Committee stage classifications for nasopharyngeal carcinoma.
Teo PM; Leung SF; Yu P; Tsao SY; Foo W; Shiu W
Cancer; 1991 Jan; 67(2):434-9. PubMed ID: 1985736
[TBL] [Abstract][Full Text] [Related]
40. Localized amyloidosis in nasopharyngeal carcinoma.
Prathap K; Looi LM; Prasad U
Histopathology; 1984 Jan; 8(1):27-34. PubMed ID: 6706312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
